<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0197">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0197">
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Penninger</surname>, 
   <given-names>J. M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Li</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhong</surname>, 
   <given-names>N.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Slutsky</surname>, 
   <given-names>A. S.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Angiotensin‐converting enzyme 2 (ACE2) as a SARS‐CoV‐2 receptor: Molecular mechanisms and potential therapeutic target</article-title>. 
  <source xml:lang="en">Intensive Care Medicine</source>, 
  <volume>46</volume>(
  <issue>4</issue>), 
  <fpage>586</fpage>–
  <lpage>590</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s00134-020-05985-9</pub-id>
  <pub-id pub-id-type="pmid">32125455</pub-id>
 </mixed-citation>
</ref>
